# Stereotactic Body Radiation Therapy (SBRT) Hepatocellular Carcinoma (COLD 2)

> **NCT00914355** · PHASE2 · COMPLETED · sponsor: **University Health Network, Toronto** · enrollment: 92 (actual)

## Conditions studied

- Hepatocellular Carcinoma

## Interventions

- **RADIATION:** Stereotactic Body Radiation

## Key facts

- **NCT ID:** NCT00914355
- **Lead sponsor:** University Health Network, Toronto
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-08
- **Primary completion:** 2020-08
- **Final completion:** 2020-12-08
- **Target enrollment:** 92 (ACTUAL)
- **Last updated:** 2021-10-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00914355

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00914355, "Stereotactic Body Radiation Therapy (SBRT) Hepatocellular Carcinoma (COLD 2)". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00914355. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*